Diagnostic yield, indications, and outcomes of cranial imaging in AML patients admitted for intensive induction or consolidation chemotherapy: a single-center experience

• Published in: Annals of hematology Vol. 102; no. 5; pp. 1045 - 1052
• Main Authors: Koschade, Sebastian E., Stratmann, Jan A., Zeiner, Pia S., Finkelmeier, Fabian, Chromik, Jörg, Steffen, Björn, Serve, Hubert, Brandts, Christian H., Ballo, Olivier
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.05.2023; Springer Nature B.V
• Subjects: Antineoplastic Combined Chemotherapy Protocols - adverse effects; Chemotherapy; Consolidation Chemotherapy; Hematology; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute - diagnostic imaging; Leukemia, Myeloid, Acute - drug therapy; Medical diagnosis; Medicine; Medicine & Public Health; Oncology; Original; Original Article; Retrospective Studies; AML; Infection; Intensive chemotherapy; Cranial imaging; Bleeding
• ISSN: 0939-5555; 1432-0584
• DOI: 10.1007/s00277-023-05178-6

Cranial imaging (CI) is a widely used diagnostic procedure, especially in acute myeloid leukemia (AML) patients with suspected bleeding or infection. However, common clinical decision rules to guide CI do not apply to AML patients and the diagnostic yield and outcomes of CI for AML patients are largely unknown. We retrospectively evaluated all CI from newly diagnosed non-promyelocytic AML patients receiving intensive induction or consolidation chemotherapy between 2007 and 2019 for imaging indications, diagnostic yield, and consequences. A total of 110 of 462 patients (24%) received CI for 152 imagings in distinct clinical situations. Forty-four patients (40%) had at least one new and acute pathological finding. Main indication was focal neurologic deficit, craniocerebral trauma, and suspected cerebral hypertension. The most common new finding was intracranial hemorrhage (13% of all imagings), followed by sinusitis (9%). CI led to therapy change in 21 patients. There were no clear associations between indications, laboratory values, and a positive imaging. Positive imaging was associated with adverse overall survival. Our study suggests that the overall rate of ordered CI was appropriate and that CI should generally be performed at a low threshold. A systematized approach to CI may further increase diagnostic yield but is complicated by variable clinical presentation.